Detox

Genetics

Inflammation

Mold

Mycotoxins

How Genes Affect Mold Detoxification

Mycotoxin and Chronic illness Summit 2022

<h6>Eric D. Gordon, M.D.</h6>
Welcome. Good afternoon and glad to have you all with us again, for another edition of Mycotoxins and Chronic Illness 2.0. Today it&#8217;s my pleasure to have Kashif Khan who is CEO of the DNA Company. And he&#8217;s gonna talk to us about how to use the information we can glean from looking at our DNA to help make a more, I&#8217;d say, stepwise and appropriate response to chronic illness. So just welcome Kashif and so tell me first off is just, you told me that when we were talking that you&#8217;re not a doctor or not a scientist, but this is your passion. So how did you wind up here?
&nbsp;

https://drsummits.s3.us-west-1.amazonaws.com/2022+Summits/Mycotoxins+and+Chronic+Illness+Summit+/Transcript+Files/Mycotoxins+_+Chronic+Illness+Summit+2022-Kashif+Khan+Transcript+File.pdf

Kashif Khan is the Chief Executive Officer and Founder of The DNA Company, where personalized medicine is being pioneered through unique insights into the human genome. With the largest study of its kind globally, The DNA Company has developed a functional approach to genomic interpretation overlaying environment, nutrition, and lifestyle on the genetic blueprint to create personalized and deterministic health outcomes.

Kashif Khan

Eric Gordon, MD is President of Gordon Medical Research Center and clinical director of Gordon Medical Associates which specializes in complex chronic illness. In addition to being in clinical practice for over 40 years, Dr. Gordon is engaged in clinical research focused on bringing together leading international medical researchers and cutting-edge clinicians. His research is focusing on ME/CFS, Lyme disease, autoimmune diseases, and autism.

How Genes Affect Mold Detoxification

Eric Gordon, MD

Kashif Khan

Summary

Content Provided By

Eric Gordon, MD

Guest Experts

Kashif Khan